23.15
Apellis Pharmaceuticals Inc Aktie (APLS) Neueste Nachrichten
Apellis Pharmaceuticals Inc.’s volatility index tracking explained2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Real time scanner hits for Apellis Pharmaceuticals Inc. explainedMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Key resistance and support levels for Apellis Pharmaceuticals Inc.Earnings Recap Summary & Daily Profit Maximizing Trade Tips - newser.com
Can Apellis Pharmaceuticals Inc. stock surprise with earnings upsideTrade Performance Summary & Target Return Focused Stock Picks - newser.com
How sentiment analysis helps forecast Apellis Pharmaceuticals Inc.Weekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
How to integrate Apellis Pharmaceuticals Inc. into portfolio analysis tools2025 Market Trends & Verified Trade Idea Suggestions - newser.com
Applying chart zones and confluence areas to Apellis Pharmaceuticals Inc.Earnings Overview Report & Daily Technical Stock Forecast Reports - newser.com
What high frequency data says about Apellis Pharmaceuticals Inc.July 2025 Update & High Accuracy Trade Alerts - newser.com
How to forecast Apellis Pharmaceuticals Inc. trends using time seriesQuarterly Risk Review & Free Expert Verified Stock Movement Alerts - newser.com
Using R and stats models for Apellis Pharmaceuticals Inc. forecastingDividend Hike & Proven Capital Preservation Tips - newser.com
Eastern Bank Cuts Position in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat
What analysts say about Apellis Pharmaceuticals Inc stockVWAP Trading Strategies & Master Stock Selection - earlytimes.in
Complement 3 Glomerulopathy Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | ChemoCentryx, Novartis, Omeros Corporation, Apellis Pharma - Barchart.com
Price momentum metrics for Apellis Pharmaceuticals Inc. explainedQuarterly Trade Summary & Daily Technical Stock Forecast Reports - newser.com
Using Bollinger Bands to evaluate Apellis Pharmaceuticals Inc.Quarterly Portfolio Summary & Growth Oriented Trading Recommendations - newser.com
Identifying reversal signals in Apellis Pharmaceuticals Inc.2025 Performance Recap & AI Driven Stock Reports - newser.com
Fierce Biotech Layoff Tracker 2025: Ascidian Tx trims team; Ferring plots 500 layoffs - fiercebiotech.com
How to monitor Apellis Pharmaceuticals Inc. with trend dashboardsJuly 2025 Retail & Reliable Price Breakout Alerts - newser.com
Why retail investors pile into Apellis Pharmaceuticals Inc. stock2025 Support & Resistance & Momentum Based Trading Signals - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Apellis Pharmaceuticals (NASDAQ:APLS) - MarketBeat
Using data tools to time your Apellis Pharmaceuticals Inc. exitJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Piper Sandler Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Raises Target Price to $28 - 富途牛牛
Published on: 2025-10-05 07:38:09 - newser.com
Volume spikes in Apellis Pharmaceuticals Inc. stock – what they meanJuly 2025 Drop Watch & Fast Moving Trade Plans - newser.com
Can Apellis Pharmaceuticals Inc. (1JK) stock sustain institutional flows2025 Price Momentum & Smart Money Movement Tracker - newser.com
Smart tools for monitoring Apellis Pharmaceuticals Inc.’s price action2025 Market Outlook & Verified Swing Trading Watchlist - newser.com
Candlestick signals on Apellis Pharmaceuticals Inc. stock todayWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
J. Safra Sarasin Holding AG Buys 68,588 Shares of Apellis Pharmaceuticals, Inc. $APLS - MarketBeat
Wall Street Has a Mixed Opinion on Apellis Pharmaceuticals (APLS) - MSN
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
What Fibonacci levels say about Apellis Pharmaceuticals Inc. reboundTrade Signal Summary & Entry Point Strategy Guides - newser.com
What MACD and RSI say about Apellis Pharmaceuticals Inc.2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com
HC Wainwright Brokers Lower Earnings Estimates for APLS - MarketBeat
Apellis Pharmaceuticals: Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders - Seeking Alpha
Apellis Pharmaceuticals CFO Timothy Sullivan sells $51,827 in stock - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):